Telehealth Anxiety Prescribing: What Psychiatrists Can Do in Illinois

If you’re a psychiatrist or PMHNP wondering whether you can manage anxiety patients through telehealth — including prescribing benzodiazepines, SSRIs, and other controlled substances remotely — the short answer is yes. But the details matter, especially when it comes to state regulations, DEA rules, and how reimbursement works.

Here’s what you actually need to know about telehealth prescribing for anxiety in 2026, without the compliance jargon.

The Federal Picture: Telehealth Prescribing Is Still Wide Open (For Now)

The COVID-era flexibilities that allowed you to prescribe controlled substances via telehealth without an initial in-person visit? They’re extended through December 2026. The DEA and HHS announced this extension in early 2026 to avoid the ‘telemedicine cliff’ that would have cut off millions of patients from virtual psychiatric care.

What this means for you:

• You can initiate and manage anxiety treatment entirely via telehealth — including prescribing Schedule IV benzodiazepines (Xanax, Klonopin, Ativan) and even Schedule II stimulants for comorbid ADHD
• No initial in-person visit required for controlled substance prescriptions through at least December 2026
• The DEA is working on permanent rules expected by late 2026, which may introduce a special telemedicine prescribing registration or bring back some exam requirements

The reality check: In 2024 alone, over 7 million controlled substance prescriptions for mental health conditions were written via telemedicine. This isn’t experimental anymore — it’s standard care. But pay attention to what the DEA finalizes in late 2026, because the rules could change.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State Rules: Where You’re Licensed Matters More Than Ever

Federal rules give you the green light, but state telehealth laws add their own layer. Here’s what matters in the states with the biggest telehealth markets:

Florida

Florida explicitly allows teleprescribing of Schedule II controlled substances for psychiatric disorders — a carve-out that many states don’t have. If you’re treating a patient’s anxiety or panic disorder via telehealth in Florida, you can prescribe stimulants or other Schedule II meds if clinically appropriate.

Catch: You must be fully licensed in Florida to prescribe controlled substances remotely. Florida offers an out-of-state telehealth provider registration, but those providers can’t prescribe controlled meds — only non-controlled. You also must check Florida’s PDMP (E-FORCSE) before prescribing any controlled anxiolytic.

Texas

Texas allows telehealth prescribing of anxiety medications, including benzodiazepines, as long as you’ve established a proper patient relationship via live video (or another accepted telemedicine modality).

The exception: Texas bans telemedicine treatment of chronic pain with controlled substances. This doesn’t apply to anxiety treatment — you’re fine prescribing benzos for panic disorder. But if you’re treating someone with both anxiety and chronic pain, be careful about documentation.

Texas also participates in the Interstate Medical Licensure Compact (IMLC), which can streamline getting licensed in multiple states if you want to expand your telehealth practice.

California

California has no special telehealth restrictions beyond federal law. If you can do it in person, you can do it via video. You need a California DEA registration to prescribe controlled substances, and you must check the state PDMP, but otherwise there are no additional hoops.

California also has telehealth payment parity for private insurance (AB 744), meaning insurers can’t pay you less just because the visit was virtual. That makes the economics of telepsychiatry in California more predictable.

Worth noting: California doesn’t participate in the IMLC yet, so you need a full California medical license to treat California patients via telehealth. No shortcuts.

New York

New York integrates telehealth into standard practice with minimal extra requirements. You can prescribe anxiety meds (including controlled substances) via telemedicine as you would in person.

The compliance piece: New York has one of the strictest PDMP mandates in the country. You must check the iSTOP database before prescribing any controlled medication, every time. No exceptions, even for refills. It’s a pain administratively, but it’s the law.

New York also has insurance parity for telehealth mental health services, which means reimbursement is solid.

Pennsylvania and Illinois

Neither state has telehealth-specific prescribing prohibitions for mental health. You follow the same standards of care as in-person visits.

Pennsylvania doesn’t have a comprehensive telehealth statute (efforts stalled), so providers largely follow federal rules and professional board guidance. Most Pennsylvania insurers voluntarily reimburse telepsychiatry at parity.

Illinois has strong telehealth laws with insurance parity (2021 law) and full Medicaid coverage for tele-mental health. Illinois also has a pathway for NPs to achieve full practice authority, which affects the provider mix in that state (more on that below).

PMHNP vs Psychiatrist: Who Can Prescribe What?

This is where it gets messy. Psychiatrists (MD/DO) can prescribe any anxiety medication in any state — full stop. No supervision required, no collaborative agreements, no restrictions beyond standard medical practice.

PMHNPs? It depends entirely on where they’re licensed.

Full Practice Authority States

In states with Full Practice Authority (FPA), PMHNPs can evaluate, diagnose, and prescribe medications — including controlled substances — completely independently. Their authority for treating anxiety is essentially equivalent to a psychiatrist’s.

Examples:

• New York (FPA as of 2022) — no collaborative agreement needed, PMHNPs can prescribe all anxiety meds independently
• Arizona, Oregon, Washington — longstanding FPA states

If you’re a PMHNP in an FPA state, you operate on equal footing with psychiatrists from a prescribing standpoint (though reimbursement may differ slightly — we’ll get to that).

Restricted/Reduced Practice States

In states requiring physician collaboration or supervision, PMHNPs need a formal relationship with a physician to prescribe. The requirements vary:

Texas — PMHNPs must have a Prescriptive Authority Agreement with a Texas physician. Additionally, Texas limits NP prescribing of Schedule II controlled substances to hospital-based practices, hospice, or terminally ill patients. This means a Texas PMHNP cannot prescribe stimulants in an outpatient setting (which sometimes matters for comorbid ADHD/anxiety). Benzodiazepines (Schedule IV) are fine if the delegating physician has authorized it.

Florida — PMHNPs require a supervising psychiatrist or physician with a written protocol. Florida has a 7-day limit on Schedule II prescriptions by NPs, except for psychiatric nurse practitioners treating mental illness. So a Florida PMHNP can prescribe more than 7 days of a controlled anxiety medication (like Xanax) if they’re a Board-certified psychiatric NP treating an anxiety disorder. The physician collaboration requirement remains in place.

California — Historically very restricted (required standardized procedures with physician oversight). AB 890 (2020) changed this: As of January 2023, experienced NPs can practice without standardized physician procedures in group settings (103 NP category). Starting January 2026, qualified NPs can apply for 104 NP certification and practice fully independently, including solo telehealth for anxiety treatment. This is a huge shift — California PMHNPs who meet the experience thresholds can now operate without a supervising physician.

Pennsylvania — PMHNPs must have a Collaborative Agreement with a physician for their entire career (no pathway to independence yet). The physician must review a percentage of charts and countersign certain controlled substance prescriptions. For benzodiazepines, this often means the collaborating psychiatrist needs to be involved in the decision-making, at least initially.

Illinois — Illinois offers a pathway to full practice authority after 4,000 clinical hours + 250 CE hours. Even with FPA, Illinois NPs need a one-time physician sign-off for prescribing benzodiazepines or Schedule II narcotics (essentially a formal attestation that the NP will be prescribing those classes). After that, they can prescribe independently.

The Bottom Line for NPs

If you’re a PMHNP in a restricted state, you need a physician collaborator to prescribe anxiety meds — and that collaborator needs to be available, willing, and sometimes paid. This can be a barrier, especially in rural areas or for pure-telehealth practices where finding a local physician partner is challenging.

If you’re in an FPA state or on the pathway to independence (like California or Illinois), you have much more flexibility. But you still face the Medicare reimbursement difference (more on that next).

What You’ll Actually Get Paid

Reimbursement for medication management varies by payer, but here’s the reality for 2026:

Medicare

Medicare pays surprisingly well for psychiatric medication management:

• 90792 (initial psychiatric evaluation with medication): ~$202
• 99213 (15-minute med check): ~$95
• 99214 (25-minute med check): ~$136
• 90833 (30-minute therapy add-on): ~$81

These rates apply to telehealth visits through at least December 2024, with practical extensions into 2025 and likely through September 2025 via recent legislation. Medicare telehealth parity has been temporarily extended to prevent a sharp cutoff.

The catch: Medicare has proposed requiring an in-person visit within 6 months for tele-mental health services (and annually thereafter) for non-rural patients. Enforcement has been repeatedly delayed, but it’s something to watch. If this rule goes into effect, pure-telehealth practices might need to arrange some in-person component for Medicare patients.

Medicaid

Medicaid pays significantly less — roughly 50-60% of Medicare rates:

• 90792: ~$85
• 99213: ~$40-50

The lower rates mean you need higher volume to make Medicaid work financially. Most states now cover telepsychiatry for Medicaid at the same rate as in-person (parity laws), which helps. High patient volume can offset the lower per-visit pay, especially if you’re efficient with telehealth workflows.

Commercial Insurance

Private insurers typically pay 100-150% of Medicare rates. A 99213 med check might reimburse at $100-$120 depending on the plan and your contract.

Many states have telehealth parity laws requiring insurers to pay the same rate for virtual visits as in-person:

• California (AB 744)
• Illinois (2021 law)
• New York (parity mandate)
• Texas (no state mandate, but many insurers voluntarily pay equally)

NP Reimbursement

If you’re billing as a PMHNP (under your own NPI), Medicare reimburses at 85% of the physician fee schedule. So if a psychiatrist gets $100 for a visit, you get $85.

Some private insurers also pay NPs at a slightly lower rate (85-90%), though this varies by contract. In high-volume settings, the lower reimbursement is offset by lower salary costs (NPs typically earn less than psychiatrists), which is why telehealth platforms often employ both.

Workaround: ‘Incident to’ billing (where the NP’s service is billed under a supervising physician’s NPI at 100% rate) generally doesn’t work in psychiatry or telehealth because the criteria are too strict.

The Economics of Patient Acquisition: Why Platforms Make Sense

Here’s where most content about ‘starting a telepsychiatry practice’ gets it wrong. They’ll tell you to ‘just set up a website and run Google Ads’ or ‘optimize your Psychology Today profile’ and patients will come.

The reality: Acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ when you factor in all the real costs:

• Google Ads for mental health keywords run $15-40+ per click, and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+
• SEO takes 6-12 months of consistent investment (content creation, technical optimization, link building) before generating meaningful patient flow. Most solo providers don’t have the expertise or patience
• Directory listings (Psychology Today, Zocdoc) charge monthly subscription fees ($30-50/month) plus you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+), so total monthly cost adds up fast
• Agency/consultant fees if you outsource marketing (typically $2,000-5,000/month retainer)
• Staff time to handle leads, qualify patients, manage no-shows from cold leads
• Failed campaigns — most providers waste thousands testing channels that don’t work

Add it all up: If you’re trying to build a patient panel from scratch, you’re easily spending $3,000-5,000/month on marketing with uncertain results. And that’s assuming you have the time to manage it while also seeing patients.

The Alternative: Platforms That Handle Acquisition

This is where a platform like Klarity Health makes economic sense. Instead of gambling on marketing channels, you pay a standard listing fee per new patient lead (similar to Zocdoc’s model, but for psychiatric care).

The value proposition:

• No upfront marketing spend — no monthly retainer, no ad budget, no SEO investment
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform subscription costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

Frame it this way: Instead of spending $3,000-5,000/month on marketing and hoping it works, you pay only when a qualified patient books with you. That’s guaranteed ROI vs gambling on marketing channels.

For providers just starting in telehealth or looking to scale without the marketing headache, this removes the risk entirely. You’re not paying for clicks, impressions, or ‘brand awareness’ — you’re paying for actual patient appointments.

The Anxiety Treatment Market: Why Demand Is So High

Anxiety disorders are among the most common mental health conditions in the U.S., and the demand for medication management far outstrips supply in most states.

Provider shortages by state (psychiatrist-to-population ratio):

• Texas: 1:8,966 (well above the national average of ~1:5,000)
• Florida: 1:8,577
• Illinois: 1:5,849
• Pennsylvania: 1:4,586
• New York: 1:2,913 (among the best, but still gaps in rural areas)

These shortages, combined with rising anxiety cases post-pandemic, mean telehealth platforms can help you reach underserved areas without relocating or opening multiple offices.

Many providers are exploring multi-state licensure (via the IMLC for physicians, or individual state licenses for NPs) to tap into these underserved markets. States like Florida have special telehealth provider registrations for out-of-state providers (though with controlled substance restrictions), and Texas is an IMLC state, making expansion easier.

What to Watch in Late 2026

The DEA is expected to release permanent telemedicine prescribing regulations by late 2026. These rules will replace the temporary COVID-era flexibilities and could include:

• A special telemedicine prescribing registration (similar to the standard DEA registration but specific to virtual care)
• Possible exam requirements (either an initial in-person visit or periodic in-person checks)
• Additional safeguards around controlled substance prescribing via telehealth

The extension through December 2026 gives the DEA time to craft these rules without cutting off patient access. But providers should stay updated — what’s allowed today might change in 2027.

FAQs

Can psychiatrists prescribe benzodiazepines via telehealth in 2026?
Yes, in all 50 states, as long as you’re licensed in the state where the patient is located and follow federal DEA rules (currently extended through December 2026 with no in-person visit requirement).

Do I need an in-person visit before prescribing anxiety meds via telehealth?
Not currently. The COVID-era flexibilities allowing controlled substance prescribing without an initial in-person visit are extended through December 2026. After that, it depends on what the DEA finalizes in the permanent rules.

Can PMHNPs prescribe Xanax or other benzodiazepines independently?
It depends on the state. In Full Practice Authority states (like New York, Arizona, Oregon), yes — PMHNPs can prescribe benzodiazepines independently. In restricted states (like Texas, Pennsylvania, Florida), PMHNPs need a collaborative agreement with a physician and the physician must authorize controlled substance prescribing.

What’s the difference between a psychiatrist and a PMHNP for anxiety treatment?
From a clinical standpoint, both can evaluate, diagnose, and manage anxiety with medications. The differences are:

• Licensing: Psychiatrists have full independent prescribing authority in all states; PMHNPs need physician collaboration in many states
• Training: Psychiatrists have 4 years of medical school + 4 years of residency; PMHNPs have 2-3 years of graduate training
• Reimbursement: Medicare pays PMHNPs at 85% of physician rates; some private insurers also pay slightly less

Do telehealth parity laws apply to psychiatric medication management?
In most states, yes. California, Illinois, New York, and many others require insurers to pay the same rate for telehealth mental health services as in-person. Texas doesn’t have a state mandate, but many insurers voluntarily pay equally. Medicare has temporarily extended telehealth parity through at least late 2024, with practical extensions into 2025.

Can I prescribe Schedule II stimulants for anxiety via telehealth?
Yes, under current federal rules (through December 2026). However, some states have additional restrictions — for example, Texas NPs cannot prescribe Schedule II in outpatient settings, and Florida has a 7-day limit unless you’re a psychiatric NP treating mental illness. Psychiatrists generally face no such state restrictions.

What’s the cost per patient acquisition for DIY psychiatric marketing?
Realistically, $200-500+ per booked patient when you factor in all costs (ad spend, agency fees, staff time, failed campaigns, no-shows). SEO takes 6-12 months of investment before generating meaningful patient flow, and Google Ads for mental health keywords are expensive ($15-40+ per click with low conversion rates).

How does Klarity Health’s model compare to traditional patient acquisition?
Instead of spending thousands monthly on marketing with uncertain results, Klarity uses a pay-per-appointment model where you pay a standard listing fee per new patient lead. You get pre-qualified patients matched to your specialty, no upfront marketing spend, and built-in telehealth infrastructure. You only pay when you see patients — guaranteed ROI vs gambling on marketing channels.

Ready to Join a Telehealth Platform That Handles Patient Acquisition for You?

If you’re a psychiatrist or PMHNP tired of chasing patients through expensive marketing channels, Klarity Health offers a smarter path: pre-qualified anxiety patients matched to your availability, no upfront marketing costs, and you only pay when patients book with you.

[Explore Klarity’s provider network →]

References and Sources

The following sources were consulted to provide up-to-date information as of February 26, 2026:

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov) – Official government source on federal telehealth prescribing policy, January 2, 2026

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov) – State law text defining NP scope and telehealth rules in Florida, 2024 Statutes

3. California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov) – State regulatory guidance on new NP independent practice categories, updated 2024

4. NPNY Announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com) – NY NP association outlining changes in law, April 9, 2022

5. NursePractitionerLicense.com – Illinois NP Licensure & Limitations – Informational site citing state law for Illinois NP practice authority, updated February 12, 2024

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs